SIGACHINSE18 January 2025

Sigachi Industries Limited has informed the Exchange about Investor Presentation

Sigachi Industries Limited

To,

Date: January 18, 2025

The Manager BSE Limited P. J. Towers, Dalal Street Mumbai-400001 (BSE Scrip Code: 543389)

Dear Sir/Madam,

The Manager, National Stock Exchange of India Limited, Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai- 400051. (NSE Symbol: SIGACHI)

Sub: Investor Presentation for Q3 FY 2024-25

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015, and with reference to the subject cited, please find enclosed the Investor Presentation for Q3 FY 2024-25. The same is also uploaded on the website of the Company www.sigachi.com

This is for the information and record of the exchanges.

Thanking You,

Yours faithfully

For Sigachi Industries Limited

Vivek Kumar Company Secretary & Compliance Officer

SIGACHI INDUSTRIES LTD

Q 3 & 9 M F Y 2 5 I n v e s t o r P r e s e n t a t i o n

J a n u a r y ’ 2 0 2 5

Safe Harbour

No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. Certain statements made in this presentation may not be based on historical information or facts and may be "forward looking statements" based on the currently held beliefs and assumptions of the management of Sigachi Industries Limited (hereinafter referred to as “Sigachi” or “Company”), which are expressed in good faith and in their opinion reasonable, including those relating to the Company’s general business plans and strategy, its future financial condition and growth prospects and future developments in its industry and its competitive and regulatory environment. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance or achievements of the Company or industry results to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements, including future changes or developments in the Company’s business, its competitive environment and political, economic, legal and social conditions. Further, past performance is not necessarily indicative of future results. Given these risks, uncertainties and other factors, viewers of this presentation are cautioned not to place undue reliance on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements to reflect future events or developments. This presentation is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. This presentation does not constitute an offer or invitation to purchase or subscribe for any securities in any jurisdiction, including the United States. No part of it should form the basis of or be relied upon in connection with any investment decision or any contract or commitment to purchase or subscribe for any securities. None of our securities may be offered or sold in the United States, without registration under the U.S. Securities Act of 1933, as amended, or pursuant to an exemption from registration there from. This presentation is confidential and may not be copied or disseminated, in whole or in part, and in any manner.

Agenda

01. Operational & Financial Highlights

03. Competitive Edge

02. Business Overview

04. Annexure

About Sigachi

V I S I O N

To contribute towards creating Healthier, Happier and Joyful World while living Sigachi values- Respect, Integrity, Resourcefulness and Excellence

M I S S I O N

To ensure all our stakeholders i.e., Customers, Suppliers, Employees, Shareholders and the Planet Earth “Experience Excellence” with everything we do

P R O D U C T A N D S E R V I C E O F F E R I N G S

S I G A C H I V A L U E S

Excellence

Integrity

Respect

Resourcefulness

A Trusted Global Partner in Excipients, APIs, and Beyond

We are more than just a supplier; we are a strategic partner committed to delivering excellence, fostering sustainable growth, and supporting clients across diverse sectors. Our growth across Pharma Excipients, APIs, Nutraceuticals, Cosmetics and Food Ingredients are driven by innovation, sustainability, and a customer-first approach.

Mr. Amit Raj Sinha MD & CEO

Our Core Strengths and Capabilities

500 + Customers across 65+ Countries

5 State of the art facilities, strategically located in Hyderabad, Sultanpur, Jhagadia, Dahej & Raichur

Operating at a combined capacity of 21,700 MTPA across 3 strategic locations

Offering 100+ Products alongside tailored, customer centric solutions

Delivering consistent quality and tailored solutions to meet the evolving needs of our customers.

Global Presence

Manufacturing Facilities

Production Capacity

Product Range

Strong Customer Relationship

25%

24%

25%

Our facilities are accredited with EXCiPACT GMP, SGMP, HACCP, EDQM CEP, FSSAI, USFDA, ISO 9001:2015 and more.

1500+ global employee base

5 Years Revenue CAGR

5 Years EBITDA CAGR

5 Years PAT CAGR

Quality Compliance

Employees

Core Business More Than Doubled in 5 Years

MCC Revenue Grew 2.6x

Revenue (Rs. Mn)

MCC Revenue CAGR : 21% (FY19-FY24)

12,793

12,655

8,876

9,159

1,173

FY19

1,265

FY20

11,446

1,773

2,266

2,603

14,740

3,015

FY21

FY22

FY23

FY24

Revenue (Rs. Mn)

Volume (MTPA)

Operational and Financial Highlights

Business Overview

Competitive Edge Driving Profitability and Financial Stability

Annexure

Business Update- Q3 & 9MFY25

Its Sultanpur, Hyderabad facility was approved by Intertek on behalf of GAIN

Focused on enhancing R&D and cost-effective manufacturing

Achieved GAIN (Global Alliance for Improved Nutrition) Audit Certification

Reinforces Sigachi’s commitment to quality and leadership in food and nutrition

Committed to R&D Excellence

Striving to remain the preferred manufacturer with top- quality standards.

Other Updates

o Strategic entry into

coatings market to harness growth potential

o Expertise in

pharmaceutical formulations drives innovation.

o State-of-the-art facilities ensure superior product quality

9MFY25 – Revenue Mix

Total Income (Rs. Mn)

Total Income Growth

26.43 % YOY

3,784

2,993

Allied Trade

API

O&M MCC

9MFY24

9MFY25

ESG Performance Q3 & 9MFY25

Progressing Towards A BETTER TOMORROW, Operating Responsibly Growing Sustainably

Environment (FY23-24)

•

Reducing our impact on the environment Reduced 7.65% in Total Carbon Emissions Recycled and Reused 81.25% of the total waste generated

Social Employee Wellbeing • Great Place To Work® Certified • • • Corporate Social Responsibility • Over 12,600+ lives touched in India

74 new hires (Q3) 19% gender diversity (Q3) 0 fatalities

through CSR initiatives

Corporate Governance •

100% Average Board meeting attendance 50% Independent board directors

•

Social

Governance (FY23-24)

Shareholders: Uninterrupted Value creation by Multiple diverse Business Verticals in the conglomerate

Customers: Increased trust on brands and Products owing to respected customer-first global avatar

People : Unlocks intrinsic motivation to explore various opportunities inside the system

Community: Larger expenditure towards CSR & Significant increase in ESG focus to achieve sustainability goals

Q3FY25 Financial Highlights

Revenue from Operational Income (Rs. Mn)

Rs. 1,394 Mn

25.70 % YOY

EBITDA (Rs. Mn)

Rs. 332 Mn

46.90 % YOY

Revenue Contribution %

83%

66%

PAT (Rs. Mn)

Margins

Rs. 205 Mn

26.54 % YOY

EBITDA : 23.81%

343 bps (YoY)

PAT : 14.70% 9 bps (YoY)

24%

Allied Trades

API

Operations and Management

MCC

Q3FY24

Q3FY25

9MFY25 Financial Highlights

Revenue from Income* (Rs. Mn)

Rs. 3,721 Mn

26.22 % YOY

EBITDA* (Rs. Mn)

Rs. 835 Mn

38.47 % YOY

Revenue Contribution %

80%

76%

PAT (Rs. Mn)

Margins

Rs. 542 Mn

29.04 % YOY

* Includes Revenue from PLI

EBITDA : 22.44%

199 bps (YoY)

PAT : 14.56% 32 bps (YoY)

12%

Allied Trades

API

Operations and Management

MCC

9MFY24

9MFY25

Q3 & 9MFY25 Story in Charts

5 2 Y F 3 Q

5 2 Y F M 9

Revenue from Operations (Rs. Mn)

EBITDA(Rs. Mn) & EBITDA Margin

PAT (Rs. Mn) & PAT Margin

20.38%

23.81%

14.61%

14.70%

1,109

Q3FY24

1,394

226

332

162

205

Q3FY25

Q3FY24

Q3FY25

Q3FY24

Q3FY25

20.45%

22.44%

14.24%

14.56%

2,948

3,721

603

835

420

542

9MFY24

9MFY25

9MFY24

9MFY25

9MFY24

9MFY25

Uptick in MCC Quantity

Volume of Microcrystalline Cellulose (In MT)

39.39%

22.50 %

3,874

4,676

5,400

11,036

13,520

Q3FY24

Q2FY25

Q3FY25

9MFY24

9MFY25

Revenue Growth in MCC (Rs.Mn)

29.03%

Key Drivers

2,232

2,880

9MFY24

9MFY25

Revenue in MCC Experienced Robust Growth

Attributed to Increased Demand and Ramp up in Capacity Utilization

Average Price of MCC for the 9M FY25 was at Rs 212.97 per kg

Revenue Growth in O&M (Rs.Mn)

17.30%

Key Drivers

• Revenue Growth is mainly attributable to increase in customers.

305

260

9MFY24

9MFY25

Strategic Alliance to Drive Expansion-JVs

Expansion in UAE

Strategic Growth in Saudi Arabia

Formation of Sigachi Global Joint Venture

Sigachi Arabia Joint Venture

o Partnership Structure: Sigachi MENA FZCO, a wholly owned subsidiary of the company, partners with iConsult Trading Consultancy LLC, a subsidiary of iMass Investments, UAE, forming a joint venture named Sigachi Global

o Market Focus: The JV aims to enter and expand in the UAE's growing food and pharmaceutical sectors, leveraging the region's market potential.

o Ownership Stake: Sigachi MENA FZCO will hold a 75% stake in Sigachi Global, while iConsult will retain a 25% stake.

o Partnership Structure: Sigachi Arabia, a JV

between Sigachi MENA FZCO and Saudi National Projects Investment Limited (SNP Global)

o Revenue Sources: Revenue is expected primarily from Saudi Government Tenders and partnerships with large corporate clients

o Local Market Leverage: By establishing a local presence, Sigachi Arabia is positioned to capitalize on emerging opportunities within the Saudi market.

o Ownership Stake: Sigachi MENA FZCO holds a 75% stake in Sigachi Arabia, with SNP holding 25%.

Strategic Priorities and Way Forward

MCC

Market Expansion

API

CCS

O&M

o Enhanced Utilization:

Striving for 80% Capacity Utilization of added Capacity by FY26

Geographic Expansion: Deepen market penetration with existing customers and expand into new regions

Broaden Market Footprint: Target B2B growth in human nutrition and expand excipient exports across 60 countries

o Portfolio Integration:

Seamlessly incorporate the new API unit with existing excipient offerings for a comprehensive customer solution

o Enter Regulated Market:

Pursuing EU Approvals and Securing 9 CEPs in FY25 for Critical APIs to enter Regulated Market

o Commercializing CCS : Aim to commercialize CCS within 18 months.

o Advanced O&M Services: Focus

on specialty chemicals, petrochemicals, water treatment, and pharma plants, leveraging industry 4.0 technologies for enhanced efficiency and compliance

Income Statement Q3 & 9MFY25

Particulars (Rs. Mn)

Revenue from Operations*

Total Expenses

EBITDA

EBITDA Margin

Depreciation and Amortization

Finance Cost

Other Income

PBT

PBT Margin

Tax Expense

PAT

PAT Margin

Other Comprehensive Income

Total Comprehensive Incomes

Basic EPS (Rs Per Share)

Diluted EPS (Rs Per Share)

Q3FY25

Q3FY24

YoY

Q2FY25

1,394

1,062

332

1,109

883

226

25.70%

20.27%

46.90%

1,370

1,077

293

QoQ

1.75%

(1.39)%

13.31%

9MFY25

9MFY24

YoY

3,721

2,886

835

2,948

2,345

603

26.22%

23.07%

38.47%

23.81%

20.38%

343 Bps

21.38%

243 Bps

22.44%

20.45%

199 Bps

267

197

35.53%

265

0.75%

110

696

525

19.15%

19.33%

(18) Bps

21.22%

(207) Bps

18.70%

17.80%

205

162

77.14%

26.54%

210

12.72%

(2.38)%

154

542

105

420

14.70%

14.61%

9 Bps

16.81%

(211) Bps

14.56%

14.24%

206

0.65

0.52

(1)

161

0.51

0.43

27.96%

30.00%

20.93%

211

0.66

0.63

(2.36)%

(1.51)%

(17.46)%

545

1.71

1.37

(1)

419

1.35

1.13

32.57%

90 Bps

46.67%

29.04%

32 Bps

30.07%

26.67%

21.23%

All numbers are on Consolidated Basis ; *9MFY25- Includes Rs.121 Mn as PLI Income.

Operational and Financial Highlights

Business Overview

Competitive Edge Driving Profitability and Financial Stability

Annexure

Sigachi Industries – Distinct Value Proposition

Sigachi Industries Ltd: Leading Manufacturer of Pre-Formulation Excipients

Presence in the Pharmaceutical Ecosystem

Competitive Edge

Largest MCC Manufacturing companies in India

Growth in API product portfolio and CEP Filings in pipeline

Present Across the Pharma Ecosystem

Pharma & Formulations

MAIN IDEA

Pharma & API Intermediates

Pharma Excipients

Film Coatings, F&N Coatings

Formulators

Doctors

End Customers

Moving Up the Value chain by Introducing Value Added and Margin Accretive Products in the Product Basket

One of the Largest Manufacturers of MCC in the World

Maximizing Capacity: Efficient Utilization (9M FY25)

8,400 MTPA

6,900 MTPA

6,400 MTPA

70.03%

98.47%

68.46%

4,800

3,600

3,300

3,600

6,400

Dahej

Jhagadia

Hyderabad

Total Capacity

Added Capacity (MTPA)

Capacity Utilization%

The capacity (7,200 MTPA) added in Q4FY24 resulted in an increase to total capacity of 21,700 MTPA

Leading MCC Manufacturer in India

Operating at a combined capacity of 21,700 MTPA across 3 strategic locations

Expanded capacity has achieved 25% utilization in 9MFY25

Anticipated annual growth in capacity utilization: 20%- 25% YoY

Robust Growth in O&M Business

Revenue Tripled

O&M Revenue (Rs. Mn)

351

265

110

122

134

FY19

FY20

FY21

FY22

FY23

FY24

Trusted Partners o Gujarat Alkalies o Aditya Birla Group o ONGC Petro Additions o Lords Chloro Alkali Limited

Asset Light Model o Zero Capex Requirement o Contracts Win to Boost RoE and

RoCE

Research & Product Excellence

Advanced Manufacturing Facilities across 5 Strategic Locations

Hyderabad Plant

Dahej SEZ Plant

Jhagadia Plant

Trimax Biosciences API Plant

Quality Assurance through Cutting-edge Facilities, Expert R&D, Accreditation and USFDA approved facility for Manufacturing Critical & Advanced intermediates. DMF for Coatings

Manufacturing Units o Five manufacturing facilities

(Telangana, Gujarat, Karnataka) including SEZ and dedicated nutritional premix facility.

Research and Development o Two state-of-the-art R&D labs located in Dahej and Jhagadia focusing on performance-oriented approaches and in-house technologies

Expansion Plans

Accredited Laboratory

o Expanding Dahej, Jhagadia

Capacities for MCC;

o Setting up New Dahej Unit for

CCS

o Laboratory at Jhagadia

accredited by Department of Science and Industrial Research (DSIR).

Ongoing Commitment to R&D Investment

Trademarks

Patent Filed

Investment in Intellectual Properties : R&D (In Rs. Mn)

44.12

FY22

37.41

FY23

CEP

49.6

FY24

Quality Assurance: Certifications & Accreditation

Ensures quality control and assurance in all manufacturing units, with various certifications for processes and raw materials

Operational and Financial Highlights

Business Overview

Competitive Edge Driving Profitability and Financial Stability

Annexure

Achieving 3x Growth in Revenue and PAT

Revenue (Rs. Mn)

EBITDA (Rs. Mn)

20.1%

21.2%

PAT (Rs. Mn) PAT

16.0%

15.7%

4,106

3,087

2,529

1,329

1,439

1,960

19.4%

19.2%

14.7% 14.6%

14.4% 14.3%

17.8%

259.6

247.6

387.9

530.4

587.3

766.5

190.1

203.2

302.6

400.4

435.4

572.0

FY19

FY20

FY21

FY22

FY23

FY24

FY19

FY20

FY21

FY22

FY23

FY24

FY19

FY20

FY21

FY22

FY23

FY24

Revenue (Rs. Mn)

EBITDA (Rs.Mn)

EBITDA Margin

PAT (Rs. Mn)

PAT Margin

Margin

EBITDA

PAT

5 Years CAGR

5 Year Average Margin

24%

25%

19.6%

14.9%

Nos. are consolidated basis

Sustainable Margins

Returns to Stake holders picking up..

20.1%

17.8%

19%

21.2%

20%

16%

15.7%

16.0%

14.7%

14.6%

19.4%

19.2%

18.9%

17%

14.4%

14.34%

52.1%

42.4%

34.1%

37.4%

31.5%

32.1%

22.2%

19.7%

17.6%

16.2%

13.64%

16.41%

FY19

FY20

FY21

FY22

FY23

FY24

EBITDA Margin

EBIT Margin

PAT Margin

FY19

FY20

FY21

ROCE

FY22

ROE

FY23

FY24

ROCE calculated after adjusting for CWIP

Low Debt: Maximizing Financial Stability

Gross Block (Rs. Mn)

Net Debt to Equity and Interest Coverage Ratio

2,157

0.46

366.1

416.5

682.5

503.3

1,151

FY19

FY20

FY21

FY22

FY23

FY24

0.28

FY19

FY20

7.52

10.56

31.04

0.02

FY21

45.31

13.68

0.03

0.13

FY22

FY23

FY24

-0.15

9.82

Net Debt to Equity

Interest Coverage Ratio

Cash Flow

To Drive Future Growth

Cash Flows from Operation (Rs. Mn)

Capex (Rs. Mn)

296

290

145

121

129

FY19

FY20

FY21

FY22

FY23

FY24

1,007

852

FY21

243

FY22

FY23

FY24

Operational and Financial Highlights

Business Overview

Competitive Edge Driving Profitability and Financial Stability

Annexure

Historical Income Statement

Particulars (Rs. Mn)

Revenue from Operations*

Total Expenses

EBITDA

EBITDA Margin

Depreciation and Amortisation

Finance costs

Other Income

PBT

PBT Margin

Tax Expense

PAT

PAT Margin

Other Comprehensive Income

Total Comprehensive Income

Basic EPS

Diluted EPS

FY21

1,928

1,540

388

FY22

2,503

1,972

531

20.12%

21.21%

385

20.0%

303

15.72%

304

1.31

516

20.6%

116

400

15.98%

-6

394

1.54

FY23

3,020

2,433

587

19.43%

545

18.0%

109

436

14.43%

437

1.41

FY24

3,989

3,223

766

19.20%

108

117

697

17.47%

125

572

14.34%

572

1.81

1.54

9MFY25

3,721

2,886

835

22.44%

110

696

18.70%

154

542

14.56%

545

1.71

1.37

All numbers are on Consolidated Basis ; *9MFY25- Includes Rs.121 Mn as PLI Income

Historical Balance Sheet

Particulars (Rs. Mn)

NON-CURRENT ASSETS

a) Property, plant and equipment

b) Capital work-in-progress

c) Intangible assets

d) Goodwill

e) Right of Use Assets

f) Financial assets

i) Investments

ii) Other Financial Assets

g) Other non-current assets

CURRENT ASSETS

a) Financial Assets

i) Trade Receivables

ii) Cash and cash equivalents

iii) Bank balances other than above

iv) Other financial assets

b) Other current assets

c) Inventories

TOTAL ASSETS

All numbers are on Consolidated Basis

FY21

463

376

871

358

159

100

212

FY22

1,069

527

351

1,799

601

291

403

128

305

FY23

1,964

960

349

257

225

164

1,774

802

137

190

110

466

FY24

3,809

1,711

966

547

277

199

3,133

1,500

174

396

163

192

707

H1FY25

3,911

2,757

547

287

206

3,616

1,723

398

285

216

911

1,334

2,868

3,738

6,942

7,527

Historical Balance Sheet

Particulars (Rs. Mn)

EQUITY

Equity Share Capital

Other Equity

Equity attributable to the owners of the company

Minority Interest

NON-CURRENT LIABILITIES

a) Financial Liabilities

i) Borrowings

ii) Lease Liability

b) Provisions

c) Deferred tax liabilities (net)

CURRENT LIABILITIES

a) Financial Liabilities

i) Borrowings

ii) Lease Liabilities

iii) Trade Payables

iv) Other financial liabilities

b) Other current liabilities

c) Current tax liabilities (Net)

TOTAL LIABILITIES

TOTAL EQUITY AND LIABILITIES

All numbers are on Consolidated Basis

FY21

942

865

942

322

183

392

1,334

FY22

2,277

307

1,970

2,277

515

332

106

591

2,868

FY23

2,683

307

2,376

2,683

308

231

747

395

208

1,055

3,738

FY24

4,410

328

3,968

4,296

114

653

266

205

164

1,878

924

479

335

2,531

6,942

H1FY25

4,820

333

4,384

4,717

102

759

326

229

189

1,948

1,022

500

312

2,707

7,527

Key Milestones

1989 Incorporated as ‘Sigachi Chloro- Chemicals Private Limited

2000 o Launched premium-grade

MCC production

o Installed advanced spray drier

and multi-fuel furnace

o Capacity boosted from 720 to

1080 MTPA

2010 Commenced the commercial production of MCC at manufacturing unit situated at Jhagadia

2014 Merger of Sigachi Cellulose Private Limited and Sigachi Plasticizers Private Limited with the company

2023 Expanded Capacity to 21,000 MTPA, the Largest MCC Manufacturing Company in India

2024 Sigachi MENA FZCO, a wholly owned subsidiary, has announced the formation of joint ventures, Sigachi Arabia and Sigachi Global.

1989

1998

2000

2009

2010

2012

2014

2021

2023

2024

2024 2025 2024 2024

1998 Commenced its export operations by exporting its product

2009 Setting up of 100 % export oriented unit (“EOU”) for manufacturing MCC in the SEZ at Dahej, Gujarat

2012 Commenced the Commercial production of MCC at the manufacturing unit situated at Dahej

2021 Got listed on NSE & BSE on Nov 15, 2021

2023 Acquired Trimax Biosciences Pvt Ltd to expand into API product offerings

2025

Achieved GAIN (Global Alliance for Improved Nutrition) Audit Certification

Sigachi MENA FZCO, a wholly owned subsidiary, has formed a joint venture with Saudi National Projects Investment (SNP) to enter the growing Saudi Arabian market.

Strong Leadership

Distinct, high performing businesses aligned with business drivers and market requirements

Rabindra Prasad Sinha Whole Time-Director & Chairman

Chidambarnathan Shanmuganathan Whole Time-Director & Vice Chairman

Amit Raj Sinha Managing Director & CEO

Lijo Chacko CEO Sigachi MEA

Subbarami Reddy Oruganti Chief Financial Officer

THANK YOU!

SIGACHI INDUSTRIES LTD

Corporate Office: Plot No. G 57/2, Survey no.70 C 174, Sultanpur Village, Patancheru Mandal, Hyderabad 502319, Sanga Reddy District, Telangana, India. Landline +91 8455242055/56/57

Registered office: 2nd floor, Kalyans Tulsiram Chambers, Madinaguda, Hyderabad 500049, Telangana, India. Landline +91 40 40114874 /75/76

GO INDIA ADVISORS – IR FIRM

Ms. Priya Sen

Ms. Sana Kapoor

Ms. Sheetal Khanduja

priya@goindiaadvisors.com

sana@goindiaadvisors.com

M : +91 8334841047

M:+91 8146550469

sheetal@goindiaadvisors.com

M: +91 9769364166

← All Transcripts SIGACHI Stock Page →

Sigachi Industries Limited has informed the Exchange about Investor Presentation

Market Movers